Compare KDP & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KDP | HLN |
|---|---|---|
| Founded | 1981 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Package Goods/Cosmetics |
| Sector | Consumer Staples | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4B | 43.7B |
| IPO Year | 2007 | N/A |
| Metric | KDP | HLN |
|---|---|---|
| Price | $26.09 | $9.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 1 |
| Target Price | ★ $34.24 | N/A |
| AVG Volume (30 Days) | ★ 9.3M | 7.9M |
| Earning Date | 04-23-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.53% | 1.84% |
| EPS Growth | ★ 45.71 | N/A |
| EPS | ★ 1.53 | N/A |
| Revenue | ★ $16,603,000,000.00 | N/A |
| Revenue This Year | $59.03 | $6.77 |
| Revenue Next Year | $14.33 | $4.42 |
| P/E Ratio | ★ $17.06 | $49.05 |
| Revenue Growth | ★ 8.16 | N/A |
| 52 Week Low | $24.88 | $8.71 |
| 52 Week High | $35.94 | $11.42 |
| Indicator | KDP | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 36.59 |
| Support Level | $24.95 | $9.60 |
| Resistance Level | $28.38 | $9.96 |
| Average True Range (ATR) | 0.63 | 0.13 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 62.74 | 0.00 |
Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. The company controls production and route to market for its own brands through in-house manufacturing plants and distribution infrastructure and leverages these facilities to manufacture and distribute for third-party coffee and beverage brands via licensing and partnership agreements. The US and Canada make up 95% of revenue, with the rest from Mexico.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.